| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/24/2008 | WO2008019967A3 Phenyl, pyridine and quinoline derivatives |
| 04/24/2008 | WO2008011116A3 Aza-peptide protease inhibitors |
| 04/24/2008 | WO2007148344A3 Process for the preparation of olmesartan medoxomil |
| 04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/24/2008 | US20080097103 Imidazole-2-thiones |
| 04/24/2008 | US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 04/24/2008 | US20080097099 Insecticides; for human or veterinary medicine; preparing heterocyclic amide and imine derivatives |
| 04/24/2008 | US20080097040 Capping polycarbonates or polyphenylene ethers with nucleophilic groups capped with a triazine moiety such as 2-allyloxy-4,6-bis(2-carbomethoxyphenoxy)-1,3,5-triazine |
| 04/24/2008 | US20080096949 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 04/24/2008 | US20080096929 enzyme myeloperoxidase inhibitor; 5-Phenoxymethyl-4-(dihydrofuran-2-one-3-yl)-2,4-dihydro-[1,2,4]triazole-3-thione; treatment or prophylaxis of neuroinflammatory disorders including multiple sclerosis, Alzheimer's disease, Parkinson's disease and stroke, COPD, asthma, inflammatory bowel disease |
| 04/24/2008 | US20080096913 peroxisome proliferator-activated receptor agonists; congestive heart failure, atherosclerosis, arteriosclerosis, obesity, hyperlipidemia, hypoalphalipoproteinemia, Syndrome X, diabetes, insulin resistance; 3-[5-Methoxy-1-(3-methoxy-benzyl)-1H-indol-3-yl]-propionic acid |
| 04/24/2008 | US20080096888 Novel compounds as opioid receptor modulators |
| 04/24/2008 | US20080096887 Benzene, Pyridine, and Pyridazine Derivatives |
| 04/24/2008 | US20080096885 Methyl 1-(2-fluorophenyl)-2-[(3-methoxy-2-phenylquinolin-4-yl)carbonyl]hydrazinecarboxylate; schizophrenia |
| 04/24/2008 | US20080096884 phosphodiesterase inhibitors; inflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis |
| 04/24/2008 | US20080096049 capable of switching between the two states in response to at least actinic radiation; thermally reversible |
| 04/24/2008 | DE102006048924A1 Acylaminopyrazole Acylaminopyrazole |
| 04/24/2008 | CA2666401A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 04/24/2008 | CA2665204A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 04/23/2008 | EP1914233A1 Peripherally-selective inhibitors of dopamine-b-hydroxylase and method of their preparation |
| 04/23/2008 | EP1914229A1 Novel cercosporamide derivative |
| 04/23/2008 | EP1912970A2 Acyltryptophanols for fertility control |
| 04/23/2008 | EP1912968A1 Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds |
| 04/23/2008 | EP1912967A1 Quinoline derivatives as neurokinin receptor antagonists |
| 04/23/2008 | EP1912966A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 04/23/2008 | EP1912948A1 Antibacterial quinoline derivatives |
| 04/23/2008 | EP1912662A2 Peptide deformylase inhibitors |
| 04/23/2008 | EP1635828B1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 04/23/2008 | EP1474145B1 Quinoline derivatives as npy antagonists |
| 04/23/2008 | EP1387836B1 Phthalazine derivatives with angiogenesis inhibiting activity |
| 04/23/2008 | EP1333834B1 Antiinflammation agents |
| 04/23/2008 | EP1216230B1 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | EP0998459B1 Pyridine derivatives |
| 04/23/2008 | CN101166737A Phosphodiesterase 4 inhibitors |
| 04/23/2008 | CN101166725A Pyridylacetic acid compound |
| 04/23/2008 | CN101166723A New compound for the treatinginflammatory disease |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383129C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/22/2008 | US7361773 dealkylation of a benzodioxane aniline in presence of chloroethanol |
| 04/22/2008 | US7361771 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 04/22/2008 | US7361755 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines |
| 04/22/2008 | US7361682 Indole derivatives as H3 inverse agonists |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | US7361665 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia |
| 04/22/2008 | US7361663 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor Xa |
| 04/22/2008 | US7361657 Drugs for treatment of respiratory syncytial virus and salt formation |
| 04/22/2008 | US7361649 β-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | CA2362697C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments |
| 04/22/2008 | CA2210693C Pyrazol-4-yl-benzoyl derivatives and their use as herbicides |
| 04/17/2008 | WO2008045564A2 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044667A1 Stat3/5 activation inhibitor |
| 04/17/2008 | WO2008044632A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | WO2008043996A2 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil |
| 04/17/2008 | WO2008043788A2 Novel compounds |
| 04/17/2008 | WO2008043544A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 04/17/2008 | WO2008027542A3 5-substituted isoindoline compounds |
| 04/17/2008 | WO2008011117A3 Antiviral protease inhibitors |
| 04/17/2008 | WO2007146323A3 Substituted cyanopyridines as protein kinase inhibitors |
| 04/17/2008 | WO2005047266A9 Aryl imidazoles and their use as anti-cancer agents |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090891 Administering calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 04/17/2008 | US20080090828 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | DE102006048042A1 Acylaminoimidazole und Acylaminothiazole Acylaminoimidazole and Acylaminothiazole |
| 04/17/2008 | CA2666177A1 Acylaminoimidazoles and acylaminothiazoles |
| 04/17/2008 | CA2666084A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | CA2665000A1 Stat3/5 activation inhibitor |
| 04/17/2008 | CA2663981A1 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil |
| 04/16/2008 | EP1911757A2 Method of preparation of 3-(1,3-Dihydroimidazole-2-thione-1-yl)-chromanes and thiochromanes as dopamine-beta-hydroxylase inhibitors |
| 04/16/2008 | EP1911755A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911747A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators |
| 04/16/2008 | EP1910343A2 Process for the preparation of olmesartan medoxomil |
| 04/16/2008 | EP1910342A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 04/16/2008 | EP1910322A2 Novel benzo [d][1,3]-dioxol derivatives |
| 04/16/2008 | EP1910314A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 04/16/2008 | EP1910310A1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same |
| 04/16/2008 | EP1910309A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION |
| 04/16/2008 | EP1910292A1 Piperidine derivative as tachykinin receptor antagonist |
| 04/16/2008 | EP1910251A1 Method for isolating 5-substituted tetrazoles |
| 04/16/2008 | EP1909792A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 04/16/2008 | EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 04/16/2008 | CN101163698A Method for the production of 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide |
| 04/16/2008 | CN101163696A Histone deacetylase inhibitors |
| 04/16/2008 | CN101163685A Pharmaceutically active diazepanes |
| 04/16/2008 | CN101163684A Quinazoline derivative having tyrosine kinase inhibitory activity |
| 04/16/2008 | CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/16/2008 | CN101163478A Compounds for inflammation and immune-related uses |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |